🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Pennsylvania › Philadelphia

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Philadelphia, PA

7 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Fox Chase Cancer Center, Philadelphia
  • Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Ap rekriteFaz 2
  • MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • MidLantic Urology, Bala-Cynwyd · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Ap rekriteFaz 3
  • MidLantic Urology, Bala-Cynwyd · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Ap rekriteFaz 1/2
  • MidLantic Urology, Cynwyd · 5 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.